Anti-Mullerian hormone and puberty development in girls and adolescents who underwent cancer treatment.
Sarrah AyuandariAgung DewantoRizki OktasariNaafi Rizqi RahmawatiNurulita Ainun AlmaKuky Cahya HamurajibSri MulatsihPublished in: Archives of gynecology and obstetrics (2022)
Chemotherapy exposure affected DOR occurrence in 60.9% of patients with childhood and adolescence cancer. Moreover, it also altered menstrual regularity in 34.8% and delayed puberty development in 8.7% subjects.